![](https://emeatribune.com/wp-content/uploads/2024/06/apple-downgraded-kroger-upgraded-wall-streets-top-analyst-calls-980x513.jpg)
![](https://emeatribune.com/wp-content/uploads/2024/06/apple-downgraded-kroger-upgraded-wall-streets-top-analyst-calls-980x513.jpg)
‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
The biotech stocks get a lot of attention, from both stock analysts and investors, but the companies don’t exist in a vacuum. We are all familiar with their famously high overhead, but we might be less familiar with the companies behind the scenes that streamline the process. CROs, contract research organizations, are firms hired by healthcare-related companies – the biotech researchers, the pharmaceutical companies, and the medical device companies – to bring efficiencies of scale to research,
TipRanks•
EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel